Company / EPS (Diluted)
SUTRO BIOPHARMA, INC. EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$29.40
FY2025
5-year range
-$29.40 / -$0.99
FY2021-FY2025
Trend
-1151.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -1151% YoY in FY2025, a notable deviation from the 6-year average annual change of -247%.
Based on SEC 10-K filings.
-29.40 in FY2025.
Declined from $-2.29 to $-29.40 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- SUTRO BIOPHARMA, INC.'s eps (diluted) has declined for 3 consecutive years.
- In FY2025, eps (diluted) decreased 1151.1% year-over-year.
- Peak eps (diluted) was recorded in FY2020.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$29.40 | -1151.1% |
| FY2024 | -$2.35 | -2.6% |
| FY2023 | -$2.29 | -131.3% |
| FY2022 | -$0.99 | +59.3% |
| FY2021 | -$2.43 | -358.5% |
| FY2020 | $0.94 | +102.1% |
| FY2019 | -$43.95 | - |
| FY2018 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026